Insider sale: 9,855 shares reported by Bryan Lee
Bryan Lee reported insider sales of common stock under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bryan Lee reported insider sales of common stock under a 10b5-1 plan. The filing shows 9,855 shares sold on 03/04/2026 for an aggregate of $174,389.15. The filing also lists 1,756 Restricted Stock Units to be sold with an action date of 03/03/2026. Shares outstanding were 76,495,680 as of 03/05/2026.
Insights
Routine 10b5-1 insider sale disclosed; amounts and dates specified.
The excerpt lists a 10b5-1 sale of 9,855 common shares on 03/04/2026 for $174,389.15, attributed to Bryan Lee. It also lists 1,756 RSUs with an issuer sale date of 03/03/2026.
Cash‑flow treatment and plan terms are not stated in the excerpt; subsequent filings or the broker statement would provide settlement and withholding details. Observers may note the timing and quantities in the company’s next periodic filings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 144 for FIVN disclose about Bryan Lee's transactions?
Was Bryan Lee's sale part of a trading plan in the Form 144?
Does the Form 144 specify how proceeds will be used or who receives them?
Are Restricted Stock Units (RSUs) included in this Form 144 filing for FIVN?
AI-generated analysis. How Rhea-AI works. Not financial advice.